IL149840A0 - New aminopropylphosphinic acids - Google Patents

New aminopropylphosphinic acids

Info

Publication number: IL149840A0
Authority: IL; Israel
Prior art keywords: new; aminopropylphosphinic acids; acids; new aminopropylphosphinic; aminopropylphosphinic
Prior art date: 1999-12-09

Application number

IL14984000A

Other languages

English (en)

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-09

Filing date

2000-12-04

Publication date

2002-11-10

2000-10-09 Priority claimed from SE0003640A external-priority patent/SE0003640D0/xx

2000-12-04 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-11-10 Publication of IL149840A0 publication Critical patent/IL149840A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
- C07F9/4808—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
- C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

IL14984000A 1999-12-09 2000-12-04 New aminopropylphosphinic acids IL149840A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9904508A SE9904508D0 (sv)	1999-12-09	1999-12-09	New compounds
SE0003640A SE0003640D0 (sv)	2000-10-09	2000-10-09	New compounds
PCT/SE2000/002426 WO2001042252A1 (en)	1999-12-09	2000-12-04	New aminopropylphosphinic acids

Publications (1)

Publication Number	Publication Date
IL149840A0 true IL149840A0 (en)	2002-11-10

Family

ID=26655259

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14984000A IL149840A0 (en)	1999-12-09	2000-12-04	New aminopropylphosphinic acids
IL149840A IL149840A (en)	1999-12-09	2004-01-01	Aminopropylphosphinic acids

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL149840A IL149840A (en)	1999-12-09	2004-01-01	Aminopropylphosphinic acids

Country Status (33)

Country	Link
US (5)	US6576626B2 (is)
EP (2)	EP1484333A1 (is)
JP (2)	JP3914435B2 (is)
KR (1)	KR100689144B1 (is)
CN (1)	CN1198832C (is)
AR (1)	AR030541A1 (is)
AT (1)	ATE282043T1 (is)
AU (1)	AU780459B2 (is)
BR (1)	BR0016253A (is)
CA (1)	CA2397583C (is)
CZ (1)	CZ20021983A3 (is)
DE (1)	DE60015796T2 (is)
DK (1)	DK1240172T3 (is)
EE (1)	EE05067B1 (is)
ES (1)	ES2230174T3 (is)
HK (2)	HK1048321B (is)
HU (1)	HUP0300301A3 (is)
IL (2)	IL149840A0 (is)
IS (1)	IS2231B (is)
MX (1)	MXPA02005536A (is)
MY (1)	MY125414A (is)
NO (1)	NO329595B1 (is)
NZ (1)	NZ519376A (is)
PL (1)	PL201789B1 (is)
PT (1)	PT1240172E (is)
RU (1)	RU2260595C2 (is)
SE (1)	SE9904508D0 (is)
SI (1)	SI1240172T1 (is)
SK (1)	SK286904B6 (is)
TW (1)	TWI228510B (is)
UA (1)	UA71649C2 (is)
WO (1)	WO2001042252A1 (is)
ZA (1)	ZA200204127B (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9904508D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
US7319095B2 (en) *	1999-12-09	2008-01-15	Astrazeneca Ab	Use of GABAB receptor agonists
WO2002062324A2 (en) *	2001-02-05	2002-08-15	Michael Albert Kamm	A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
AR033779A1 (es) *	2001-06-08	2004-01-07	Astrazeneca Ab	Compuestos utiles en la enfermedad de reflujo
SE0201940D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination II
SE0201939D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination
SE0401653D0 (sv)	2004-06-24	2004-06-24	Astrazeneca Ab	New compounds
SE0402462D0 (sv) *	2004-10-08	2004-10-08	Astrazeneca Ab	New process
US7494985B2 (en)	2004-11-03	2009-02-24	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en)	2004-11-03	2009-07-28	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US20060160777A1 (en) *	2004-12-27	2006-07-20	Anders Lehmann	New use of GABAbeta receptor agonists
CA2632021A1 (en)	2005-12-23	2007-06-28	Astrazeneca Ab	Gaba-b receptor modulators
WO2007073298A1 (en)	2005-12-23	2007-06-28	Astrazeneca Ab	Imidazole derivatives for the treatment of gastrointestinal disorders
WO2008033572A1 (en)	2006-09-15	2008-03-20	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
EP2155762B1 (en) *	2007-05-04	2011-10-12	AstraZeneca AB	Process for the synthesis of alkyl phosphinic acids by initiation of an amine and an amineoxide
US20100317626A1 (en) *	2007-07-25	2010-12-16	Astrazeneca Ab	The Use Of (3-Amino-2-Fluoropropyl) Phosphinic Acid For Treatment Of NERD
WO2009082345A1 (en) *	2007-12-21	2009-07-02	Astrazeneca Ab	Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
WO2009082344A1 (en) *	2007-12-21	2009-07-02	Astrazeneca Ab	Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a
WO2009082348A1 (en) *	2007-12-21	2009-07-02	Astrazeneca Ab	Novel crystalline form c of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
WO2009145716A1 (en) *	2008-05-28	2009-12-03	Astrazeneca Ab	New pharmaceutical formulation useful in gerd therapy
EP2346885B1 (de)	2008-11-05	2013-08-28	Clariant International Ltd.	Verfahren zur herstellung von monocarboxyfunktionaslisierten dialkylphosphinsäuren, -estern und -salzen mittels allylalkoholen/acroleinen und ihre verwendung
WO2010051893A1 (de)	2008-11-07	2010-05-14	Clariant International Ltd	Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels acrylsäurederivaten und ihre verwendung
DE102008056341A1 (de)	2008-11-07	2010-05-12	Clariant International Limited	Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
CN102171226B (zh)	2008-11-11	2015-02-11	科莱恩金融(Bvi)有限公司	利用烯丙基化合物制备单烯丙基官能化的二烷基次膦酸、其盐或酯的方法以及它们的用途
DE102008060035A1 (de)	2008-12-02	2010-06-10	Clariant International Limited	Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060535A1 (de)	2008-12-04	2010-06-10	Clariant International Limited	Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung
DE102008063642A1 (de)	2008-12-18	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung
DE102008063668A1 (de)	2008-12-18	2010-07-01	Clariant International Limited	Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung
EP2379573B1 (de)	2008-12-18	2013-12-11	Clariant Finance (BVI) Limited	Verfahren zur herstellung von ethylendialkylphosphinsäuren, -estern und -salzen mittels acetylen und ihre verwendung
DE102008063627A1 (de)	2008-12-18	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung
DE102008064003A1 (de)	2008-12-19	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en)	2010-03-17	2011-09-22	INSERM (Institut National de la Santé et de la Recherche Médicale)	Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
US20120016021A1 (en)	2010-07-15	2012-01-19	Xenoport, Inc.	Methods of treating fragile x syndrome, down's syndrome, autism and related disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH449046A (de)	1963-07-09	1967-12-31	Ciba Geigy	Verfahren zur Herstellung neuer Aminosäuren
GB8425872D0 (en) *	1984-10-12	1984-11-21	Ciba Geigy Ag	Chemical compounds
WO1987004077A1 (en)	1986-01-03	1987-07-16	The University Of Melbourne	Gastro-oesophageal reflux composition
US4740332A (en) *	1986-05-12	1988-04-26	E. R. Squibb & Sons, Inc.	Process for preparing phosphonous acids
GB8820266D0 (en)	1988-08-26	1988-09-28	Smith Kline French Lab	Compounds
US5567840A (en)	1989-05-13	1996-10-22	Ciba-Geigy Corporation	Substituted aminoalkylphosphinic acids
US5281747A (en)	1989-05-13	1994-01-25	Ciba-Geigy Corporation	Substituted aminoalkylphosphinic acids
GB8911017D0 (en)	1989-05-13	1989-06-28	Ciba Geigy Ag	Substituted aminoalkylphosphinic acids
US5006560A (en)	1989-12-20	1991-04-09	Schering Corporation	Use of GABA-B selective agonists as anti-tussive agents
IL114631A (en) *	1990-06-22	1998-12-06	Novartis Ag	Anti-epileptic preparations containing antagonists of BABAG
FR2663934B1 (fr)	1990-06-27	1994-06-03	Adir	Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
GB9125615D0 (en) *	1991-12-02	1992-01-29	Wyeth John & Brother Ltd	Amines
AU662404B2 (en) *	1992-05-08	1995-08-31	Novartis Ag	Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
FR2722192A1 (fr)	1994-07-06	1996-01-12	Adir	Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en)	1994-10-14	1994-11-30	Glaxo Group Ltd	Medicaments
SE9603408D0 (sv) *	1996-09-18	1996-09-18	Astra Ab	Medical use
US7319095B2 (en) *	1999-12-09	2008-01-15	Astrazeneca Ab	Use of GABAB receptor agonists
SE9904507D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
SE9904508D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds

1999
- 1999-12-09 SE SE9904508A patent/SE9904508D0/xx unknown
2000
- 2000-04-12 UA UA2002064507A patent/UA71649C2/uk unknown
- 2000-11-27 TW TW089125135A patent/TWI228510B/zh not_active IP Right Cessation
- 2000-12-04 ES ES00983634T patent/ES2230174T3/es not_active Expired - Lifetime
- 2000-12-04 CA CA2397583A patent/CA2397583C/en not_active Expired - Fee Related
- 2000-12-04 AT AT00983634T patent/ATE282043T1/de active
- 2000-12-04 WO PCT/SE2000/002426 patent/WO2001042252A1/en active IP Right Grant
- 2000-12-04 EP EP04021533A patent/EP1484333A1/en not_active Withdrawn
- 2000-12-04 AU AU20364/01A patent/AU780459B2/en not_active Ceased
- 2000-12-04 PT PT00983634T patent/PT1240172E/pt unknown
- 2000-12-04 JP JP2001543550A patent/JP3914435B2/ja not_active Expired - Fee Related
- 2000-12-04 IL IL14984000A patent/IL149840A0/xx active IP Right Grant
- 2000-12-04 BR BR0016253-1A patent/BR0016253A/pt not_active IP Right Cessation
- 2000-12-04 RU RU2002113909/04A patent/RU2260595C2/ru not_active IP Right Cessation
- 2000-12-04 EE EEP200200286A patent/EE05067B1/xx not_active IP Right Cessation
- 2000-12-04 SK SK764-2002A patent/SK286904B6/sk not_active IP Right Cessation
- 2000-12-04 HU HU0300301A patent/HUP0300301A3/hu unknown
- 2000-12-04 KR KR1020027007355A patent/KR100689144B1/ko not_active IP Right Cessation
- 2000-12-04 PL PL364795A patent/PL201789B1/pl not_active IP Right Cessation
- 2000-12-04 DK DK00983634T patent/DK1240172T3/da active
- 2000-12-04 SI SI200030561T patent/SI1240172T1/xx unknown
- 2000-12-04 MX MXPA02005536A patent/MXPA02005536A/es active IP Right Grant
- 2000-12-04 CZ CZ20021983A patent/CZ20021983A3/cs unknown
- 2000-12-04 NZ NZ519376A patent/NZ519376A/en not_active IP Right Cessation
- 2000-12-04 CN CNB008168989A patent/CN1198832C/zh not_active Expired - Fee Related
- 2000-12-04 EP EP00983634A patent/EP1240172B1/en not_active Expired - Lifetime
- 2000-12-04 DE DE60015796T patent/DE60015796T2/de not_active Expired - Lifetime
- 2000-12-04 AR ARP000106418A patent/AR030541A1/es active IP Right Grant
- 2000-12-04 US US09/786,219 patent/US6576626B2/en not_active Expired - Fee Related
- 2000-12-07 MY MYPI20005746A patent/MY125414A/en unknown
2002
- 2002-05-23 ZA ZA200204127A patent/ZA200204127B/xx unknown
- 2002-06-06 IS IS6408A patent/IS2231B/is unknown
- 2002-06-07 NO NO20022728A patent/NO329595B1/no not_active IP Right Cessation
2003
- 2003-01-17 HK HK03100457.3A patent/HK1048321B/zh not_active IP Right Cessation
- 2003-04-04 US US10/406,838 patent/US6841698B2/en not_active Expired - Fee Related
- 2003-07-29 HK HK03105473A patent/HK1053125A1/xx not_active IP Right Cessation
2004
- 2004-01-01 IL IL149840A patent/IL149840A/en not_active IP Right Cessation
- 2004-12-16 US US11/016,543 patent/US7034176B2/en not_active Expired - Fee Related
2006
- 2006-04-07 US US11/400,021 patent/US7807658B2/en not_active Expired - Fee Related
- 2006-06-27 JP JP2006175983A patent/JP2006306885A/ja active Pending
2007
- 2007-07-12 US US11/776,648 patent/US20080146836A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20080146836A1 (en)	2008-06-19
NO329595B1 (no)	2010-11-22
CN1409716A (zh)	2003-04-09
BR0016253A (pt)	2002-08-27
TWI228510B (en)	2005-03-01
US20050137414A1 (en)	2005-06-23
MXPA02005536A (es)	2004-09-10
NZ519376A (en)	2003-11-28
EP1240172A1 (en)	2002-09-18
SK7642002A3 (en)	2002-12-03
RU2002113909A (ru)	2004-01-10
HK1048321B (zh)	2005-09-30
AU780459B2 (en)	2005-03-24
PL201789B1 (pl)	2009-05-29
CN1198832C (zh)	2005-04-27
CA2397583C (en)	2010-11-09
DE60015796D1 (de)	2004-12-16
AR030541A1 (es)	2003-08-27
SI1240172T1 (en)	2005-02-28
EE200200286A (et)	2003-08-15
DK1240172T3 (da)	2005-02-14
SE9904508D0 (sv)	1999-12-09
EP1240172B1 (en)	2004-11-10
NO20022728L (no)	2002-08-07
ATE282043T1 (de)	2004-11-15
WO2001042252A1 (en)	2001-06-14
RU2260595C2 (ru)	2005-09-20
IL149840A (en)	2006-04-10
UA71649C2 (en)	2004-12-15
ES2230174T3 (es)	2005-05-01
US7034176B2 (en)	2006-04-25
US20070021393A1 (en)	2007-01-25
EE05067B1 (et)	2008-08-15
ZA200204127B (en)	2003-08-25
HK1053125A1 (en)	2003-10-10
US7807658B2 (en)	2010-10-05
JP2006306885A (ja)	2006-11-09
IS2231B (is)	2007-04-15
US20020156053A1 (en)	2002-10-24
CA2397583A1 (en)	2001-06-14
AU2036401A (en)	2001-06-18
PL364795A1 (en)	2004-12-13
US6841698B2 (en)	2005-01-11
EP1484333A1 (en)	2004-12-08
JP2003516407A (ja)	2003-05-13
NO20022728D0 (no)	2002-06-07
PT1240172E (pt)	2005-02-28
SK286904B6 (sk)	2009-07-06
KR100689144B1 (ko)	2007-03-08
HUP0300301A3 (en)	2008-12-29
KR20020060992A (ko)	2002-07-19
HK1048321A1 (en)	2003-03-28
IS6408A (is)	2002-06-06
JP3914435B2 (ja)	2007-05-16
CZ20021983A3 (cs)	2002-11-13
DE60015796T2 (de)	2005-11-03
US6576626B2 (en)	2003-06-10
HUP0300301A2 (hu)	2003-06-28
MY125414A (en)	2006-07-31
US20030220303A1 (en)	2003-11-27

Legal Events

Date	Code	Title
2006-09-05	FF	Patent granted
2006-10-04	KB	Patent renewed
2007-02-12	KB	Patent renewed

Publication	Publication Date	Title
IL149840A0 (en)	2002-11-10	New aminopropylphosphinic acids
DE50002490D1 (en)	2003-07-10	Polyester-polyetherblockcopolymere
PL348244A1 (en)	2002-05-20	Substituted indolealkanoic acids
DE50008011D1 (en)	2004-11-04	Thixotropierungsmittel
DE50002614D1 (en)	2003-07-24	Sigma-delta-modulator
IL148218A0 (en)	2002-09-12	New phenylpiperazines
DE60007505D1 (en)	2004-02-05	Propargyletherderivate
HUP0202384A3 (en)	2003-03-28	Substituted phenoxyacetic acids
DE50000137D1 (en)	2002-05-16	Spirofluorenopyrane
DE59909975D1 (en)	2004-08-19	Testleck
AU1497802A (en)	2002-03-26	Ss-thio-amino acids
DE10081629D2 (en)	2003-03-13	Seilzugbefestigung
DE50009469D1 (en)	2005-03-17	Common-rail-injektor
DE60001313D1 (en)	2003-03-06	Imidazodiazepinderivate
DE50010757D1 (en)	2005-08-25	Stilbenaufheller
DE50012999D1 (en)	2006-07-27	Stirnwandisolation
DE50008218D1 (en)	2004-11-18	Common-rail-injektor
GB9905235D0 (en)	1999-04-28	Connection
DE60004080D1 (en)	2003-08-28	Centroidintegration
AU141428S (en)	2000-08-14	Turnpiece
DE50008219D1 (en)	2004-11-18	Common-rail-injektor
DE50012739D1 (en)	2006-06-14	Thermovliesstoff
DE60004674D1 (en)	2003-09-25	Carbonylierungsreaktionen
DE50005334D1 (en)	2004-03-25	Tricyclische benzoylcyclohexandion-derivate
AU140373S (en)	2000-04-12	Bumbag